The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
State-run television KRT showed Kim still using a walking stick as he inspected the airport being constructed in the capital.
The loss is a tragedy for this small tight-knit team that dreams of making the trip into space accessible to travellers not just astronauts.
Ryan Bowen had been planning this baby-piloted battle-mech since before his son was born.